Abstract
Cilostazol, a licensed clinical drug for the treatment of intermittent claudication, is a phosphodiesterase (PDE) inhibitor that selectively inhibits PDE3, a cAMP-degrading enzyme, thus elevating levels of intracellular cAMP. It has been reported that pigment production by melanocytes both tans the skin and protects against skin cancers. The effects of cilostazol in melanogenesis are as yet unknown. In this study, treatment with cilostazol was found to promote the production of melanin as well as increase both Tyrosinase enzymatic activity and expression of the Tyrosinase gene. Importantly, we also found that cilostazol led to increased expression of the microphthalmia-associated transcription factor (MITF), the "master regulator" of both melanocyte differentiation and pigment production. Interestingly, knockdown of MITF using siRNA abolished the effects of cilostazol in melanogenesis, thereby suggesting that MITF might play a critical role in melanogenesis. Increased expression of MITF was abolished by treatment with H-89, a specific protein kinase A (PKA) inhibitor, thereby suggesting that the PKA pathway plays a critical role in cilostazol-induced expression of MITF. Cilostazol in fact enhanced expression of p-CREB, which wa...Continue Reading
References
Nov 1, 1992·Pigment Cell Research·Y TomitaH Tagami
Jan 28, 2004·Cancer Research·Arlo J MillerDavid E Fisher
Jul 8, 2005·Nature·Levi A GarrawayWilliam R Sellers
Aug 11, 2006·Trends in Molecular Medicine·Carmit LevyDavid E Fisher
Nov 7, 2006·Pigment Cell Research·Bidisha SahaRanjan Bhadra
Nov 20, 2009·The Journal of Investigative Dermatology·Anissa ElfakirChristiane Guinot
Sep 8, 2010·The New England Journal of Medicine·David E Fisher, William D James
Nov 15, 2011·Journal of Neurochemistry·Baiyang ShengXiongwei Zhu
Jan 24, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Yu-Chun HuangYi-Ling Chiou
Aug 18, 2012·Experimental Dermatology·Huazhang GuoAndrzej Slominski
Dec 4, 2012·Molecular Cell·Jonathan ShoagZoltan Arany
Jan 22, 2013·Life Sciences·Byeng Chul YuIl-Whan Choi
Mar 15, 2013·Biochemical and Biophysical Research Communications·Luning ZuoZhiming Ge
Jul 12, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Jun LuJian-You Guo
Citations
Mar 10, 2015·Vascular Pharmacology·Hongliang LiWon Sun Park
Jun 28, 2016·Biochemical and Biophysical Research Communications·Xing-Hua YuanDong Hun Lee
Apr 20, 2019·Bioscience, Biotechnology, and Biochemistry·Jianzeng LiuDaqing Zhao
Oct 20, 2016·Tissue Engineering and Regenerative Medicine·Sang-Eun ChoYoung-Kwon Seo